To serve this need, MJFF's Target to Therapies Initiative will expand and mechanistically validate promising, druggable targets in the field of Parkinson's disease by identifying a shortlist of priority targets for dedicated de-risking focus over the next three -to -four years.

Three of the primary risk factors for Parkinson's disease (PD)—aging, environmental toxins and genetic mutations—all lead to impaired function of mitochondria, structures that...

The Michael J. Fox Foundation is dedicated to finding a cure for Parkinson's disease through an aggressively funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's today.

Mar 31, 2023 · This report provides a brief overview of targets of interest from MJFF’s portfolio. Profiles for emerging and advanced targets provide a summary of the current status of the target as it relates to therapeutic development, how it is connected to Parkinson's Disease, and what MJFF’s investments have been up to this point.

Oct 25, 2024 · To address this in Parkinson's disease (PD), the MJFF has established an industry- and investor-led initiative, called Targets to Therapies (T2T). It will aim to leverage the collective expertise of the PD research community to prioritize and de …

Jul 25, 2024 · This report highlights the results of a Request for Information (RFI) survey that was released in the Spring of 2024 and served as the inital step of an exciting pilot initiative known as Targets to Therapies (T2T) launched by the Michael J. Fox Foundation.

生命科学发现技术公司暨领先的抗体、试剂盒与服务提供商 Cell Signaling Technology (CST) 今天宣布与 Michael J. Fox 帕金森病研究基金会 (MJFF) 合作，为有前景的帕金森病 (PD) 靶标识别和开发高质量的单克隆抗体。能否获得经过严格验证、可重复且易于获得的靶向 PD 相关 ...

Oct 17, 2024 · The Michael J. Fox Foundation Launches 2025 "Parkinson's IQ + You" National Event Series Across the United States to Educate and Empower People and Families Living with Parkinson's Disease

The Michael J. Fox Foundation for Parkinson's Research is a US non-profit organization founded in 2000 by Canadian-American actor Michael J. Fox to find a cure for Parkinson's disease.

Our funding application guidelines cover our review process and criteria, confidentiality, conflicts of interest and special requirements. We hope this information will answer questions about our grants and ease your application process.